These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31464894)

  • 1. The role of 18F-FDG PET/CT in management of paraneoplastic limbic encephalitis combined with small cell lung cancer: A case report.
    Castagnoli H; Manni C; Marchesani F; Rossi G; Fattori S; Capoccetti F
    Medicine (Baltimore); 2019 Aug; 98(35):e16593. PubMed ID: 31464894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 18FDG PET/CT Tumoral and Neurologic Therapeutic Response in a Case of Anti-GABABR Paraneoplastic Limbic Encephalitis.
    Ouvrard E; Voulleminot P; Mennecier B; Bund C; Namer IJ
    Clin Nucl Med; 2023 Mar; 48(3):237-239. PubMed ID: 36723883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic Limbic Encephalitis Secondary to SCLC on 18F-FDG PET/CT.
    Verçosa AFA; Mota IA; Flamini MEDM; Flamini RC
    Clin Nucl Med; 2021 Jun; 46(6):494-496. PubMed ID: 33939650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of nodal staging by 18F-FDG-PET/CT in limited disease small-cell lung cancer.
    Hockmann J; Hautzel H; Darwiche K; Eberhard W; Stuschke M; Aigner C; Herrmann K; Plönes T
    Asian Cardiovasc Thorac Ann; 2023 Jul; 31(6):506-511. PubMed ID: 37438928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of standardised uptake value (SUV
    Yilmaz Demirci N; Yilmaz Ü; Biner Uslu I; Dikmen A; Yılmaz A; Erdoğan Y
    Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 26988938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small Cell Lung Cancer Staging: Prospective Comparison of Conventional Staging Tests, FDG PET/CT, Whole-Body MRI, and Coregistered FDG PET/MRI.
    Ohno Y; Yoshikawa T; Takenaka D; Koyama H; Aoyagi K; Yui M; Oshima Y; Hamabuchi N; Tanaka Y; Shigemura C; Oota S; Nomura M; Murayama K; Inui Y; Kikukawa K; Toyama H
    AJR Am J Roentgenol; 2022 May; 218(5):899-908. PubMed ID: 34877872
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of
    Al-Ibraheem A; Hirmas N; Fanti S; Paez D; Abuhijla F; Al-Rimawi D; Al-Rasheed U; Abdeljalil R; Hawari F; Alrabi K; Mansour A
    BMC Med Imaging; 2021 Mar; 21(1):49. PubMed ID: 33731050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of anti-SOX1 and anti-GABAB receptor antibodies with paraneoplastic limbic encephalitis presenting with seizures and memory impairment in small cell lung cancer: A case report.
    Gong S; Han Y; He E; Liu M; Fu X; Deng F
    Front Immunol; 2022; 13():955170. PubMed ID: 35967304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain 18F-FDG-PET characteristics in patients with paraneoplastic neurological syndrome and its correlation with clinical and MRI findings.
    Masangkay N; Basu S; Moghbel M; Kwee T; Alavi A
    Nucl Med Commun; 2014 Oct; 35(10):1038-46. PubMed ID: 25023997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of 18F-Fluorodeoxyglucose PET/CT in restaging patients with small cell lung cancer: a systematic review.
    Quartuccio N; Salem A; Laudicella R; Spataro A; Chiaravalloti A; Caobelli F; Cistaro A; Alongi P; Evangelista L
    Nucl Med Commun; 2021 Aug; 42(8):839-845. PubMed ID: 33741854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitis.
    Deuschl C; Rüber T; Ernst L; Fendler WP; Kirchner J; Mönninghoff C; Herrmann K; Quesada CM; Forsting M; Elger CE; Umutlu L
    PLoS One; 2020; 15(1):e0227906. PubMed ID: 31951636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study.
    Quartuccio N; Evangelista L; Alongi P; Caobelli F; Altini C; Cistaro A; Lambertini A; Schiorlin I; Popescu CE; Linguanti F; Laudicella R; Scalorbi F; Di Pierro G; Asabella AN; Cuppari L; Margotti S; Lima GM; Scalisi S; Pacella S; Kokomani A; Ciaccio A; Sturiale L; Vento A; Cardile D; Baldari S; Panareo S; Fanti S; Rubini G; Schillaci O; Chiaravalloti A;
    Nucl Med Commun; 2019 Aug; 40(8):808-814. PubMed ID: 31136534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis.
    Machado Medeiros T; Altmayer S; Watte G; Zanon M; Basso Dias A; Henz Concatto N; Hoefel Paes J; Mattiello R; de Souza Santos F; Mohammed TL; Verma N; Hochhegger B
    Eur Radiol; 2020 Jul; 30(7):3641-3649. PubMed ID: 32125513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Molecular Imaging with 2-Deoxy-2-[Fluorine-18] Fluoro-DGlucose Positron Emission Tomography (18F-FDG PET) for Small Cell Lung Cancer (SCLC): A Radiation Oncology Perspective.
    Sager O; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Elcim Y; Gundem E; Dirican B; Beyzadeoglu M
    Curr Radiopharm; 2019; 12(1):4-10. PubMed ID: 30465520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlative imaging with (18)F-FDG PET/CT and MRI in paraneoplastic limbic encephalitis.
    Maffione AM; Chondrogiannis S; Ferretti A; Al-Nahhas A; Rubello D
    Clin Nucl Med; 2013 Jun; 38(6):463-4. PubMed ID: 23531769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [18F]FDG PET/CT-based response assessment of stage IV non-small cell lung cancer treated with paclitaxel-carboplatin-bevacizumab with or without nitroglycerin patches.
    de Jong EE; van Elmpt W; Leijenaar RT; Hoekstra OS; Groen HJ; Smit EF; Boellaard R; van der Noort V; Troost EG; Lambin P; Dingemans AC
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):8-16. PubMed ID: 27600280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment metabolic parameters measured by 18F-FDG-PET to predict the outcome of first-line chemotherapy in extensive-stage small-cell lung cancer.
    Yu X; Zhu Y; Wang J; Song X; Zhu L; Men X; Li X; Dai D; Xu W
    Nucl Med Commun; 2017 Feb; 38(2):193-200. PubMed ID: 27977537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance Comparison Between
    Kishida Y; Seki S; Yoshikawa T; Itoh T; Maniwa Y; Nishimura Y; Ohno Y
    AJR Am J Roentgenol; 2018 Jul; 211(1):185-192. PubMed ID: 29667886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASL MRI and 18F-FDG-PET in autoimmune limbic encephalitis: clues from two paradigmatic cases.
    Dinoto A; Cheli M; Ajčević M; Dore F; Crisafulli C; Ukmar M; Sartori A; Manganotti P
    Neurol Sci; 2021 Aug; 42(8):3423-3425. PubMed ID: 33763811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.